Rowlandmiller & Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-116
| Closed | -$122K | – | 189 |
|
|
2024
Q3 | $122K | Hold |
116
| – | – | 0.02% | 168 |
|
|
2024
Q2 | $122K | Hold |
116
| – | – | 0.03% | 161 |
|
|
2024
Q1 | $112K | Hold |
116
| – | – | 0.02% | 175 |
|
|
2023
Q4 | $102K | Buy |
+116
| New | +$102K | 0.02% | 177 |
|
|
2023
Q2 | – | Sell |
-171
| Closed | -$141K | – | 185 |
|
|
2023
Q1 | $141K | Buy |
+171
| New | +$141K | 0.03% | 155 |
|